Literature DB >> 28432113

Automated quantitative characterisation of retinal vascular leakage and microaneurysms in ultra-widefield fluorescein angiography.

Justis P Ehlers1, Kevin Wang1,2, Amit Vasanji3, Ming Hu1,4, Sunil K Srivastava1.   

Abstract

Ultra-widefield fluorescein angiography (UWFA) is an emerging imaging modality used to characterise pathology in the retinal vasculature such as microaneurysms (MAs) and vascular leakage. Despite its potential value for diagnosis and disease surveillance, objective quantitative assessment of retinal pathology by UWFA is currently limited because it requires laborious manual segmentation by trained human graders. In this report, we describe a novel fully automated software platform, which segments MAs and leakage areas in native and dewarped UWFA images with retinal vascular disease. Comparison of the algorithm with human grader-generated gold standards demonstrated significant strong correlations for MA and leakage areas (intraclass correlation coefficient (ICC)=0.78-0.87 and ICC=0.70-0.86, respectively, p=2.1×10-7 to 3.5×10-10 and p=7.8×10-6 to 1.3×10-9, respectively). These results suggest the algorithm performs similarly to human graders in MA and leakage segmentation and may be of significant utility in clinical and research settings. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Diagnostic tests/Investigation; Imaging; Macula; Retina

Mesh:

Year:  2017        PMID: 28432113      PMCID: PMC5512291          DOI: 10.1136/bjophthalmol-2016-310047

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  13 in total

1.  Ultra-wide-field fluorescein angiography of the ocular fundus.

Authors:  Ayyakkannu Manivannan; Jarka Plskova; Alison Farrow; Sandra Mckay; Peter F Sharp; John V Forrester
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

2.  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

3.  The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Authors:  Paul Mitchell; Francesco Bandello; Ursula Schmidt-Erfurth; Gabriele E Lang; Pascale Massin; Reinier O Schlingemann; Florian Sutter; Christian Simader; Gabriela Burian; Ortrud Gerstner; Andreas Weichselberger
Journal:  Ophthalmology       Date:  2011-04       Impact factor: 12.079

4.  Photocoagulation therapy for diabetic eye disease. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  JAMA       Date:  1985-12-06       Impact factor: 56.272

5.  Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1981-07       Impact factor: 12.079

6.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

7.  Precise montaging and metric quantification of retinal surface area from ultra-widefield fundus photography and fluorescein angiography.

Authors:  Daniel E Croft; Jano van Hemert; Charles C Wykoff; David Clifton; Michael Verhoek; Alan Fleming; David M Brown
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2014 Jul-Aug       Impact factor: 1.300

8.  Color photography vs fluorescein angiography in the detection of diabetic retinopathy in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1987-10

9.  Photocoagulation for diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group.

Authors:  F L Ferris
Journal:  JAMA       Date:  1991-09-04       Impact factor: 56.272

10.  Automated detection of leakage in fluorescein angiography images with application to malarial retinopathy.

Authors:  Yitian Zhao; Ian J C MacCormick; David G Parry; Sophie Leach; Nicholas A V Beare; Simon P Harding; Yalin Zheng
Journal:  Sci Rep       Date:  2015-06-01       Impact factor: 4.379

View more
  21 in total

1.  Quantitative Ultra-Widefield Angiography and Diabetic Retinopathy Severity: An Assessment of Panretinal Leakage Index, Ischemic Index and Microaneurysm Count.

Authors:  Justis P Ehlers; Alice C Jiang; Joseph D Boss; Ming Hu; Natalia Figueiredo; Amy Babiuch; Katherine Talcott; Sumit Sharma; Jenna Hach; Thuy Le; Alison Rogozinski; Leina Lunasco; Jamie L Reese; Sunil K Srivastava
Journal:  Ophthalmology       Date:  2019-06-08       Impact factor: 12.079

2.  Longitudinal Panretinal Leakage and Ischemic Indices in Retinal Vascular Disease after Aflibercept Therapy: The PERMEATE Study.

Authors:  Natalia Figueiredo; Sunil K Srivastava; Rishi P Singh; Amy Babiuch; Sumit Sharma; Aleksandra Rachitskaya; Katherine Talcott; Jamie Reese; Ming Hu; Justis P Ehlers
Journal:  Ophthalmol Retina       Date:  2019-09-10

3.  Sustained Inhibition of NF-κB Activity Mitigates Retinal Vasculopathy in Diabetes.

Authors:  Rubens P Homme; Harpal S Sandhu; Akash K George; Suresh C Tyagi; Mahavir Singh
Journal:  Am J Pathol       Date:  2021-02-26       Impact factor: 4.307

4.  Factors Affecting Predominantly Peripheral Lesion Identification and Grading.

Authors:  Mohamed Ashraf; Abdulrahman Rageh; Michael Gilbert; Dorothy Tolls; Alan Fleming; Ahmed Souka; Samir El-Baha; Jerry D Cavallerano; Jennifer K Sun; Lloyd Paul Aiello; Paolo S Silva
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.048

5.  Deep learning-enabled ultra-widefield retinal vessel segmentation with an automated quality-optimized angiographic phase selection tool.

Authors:  Duriye Damla Sevgi; Sunil K Srivastava; Charles Wykoff; Adrienne W Scott; Jenna Hach; Margaret O'Connell; Jon Whitney; Amit Vasanji; Jamie L Reese; Justis P Ehlers
Journal:  Eye (Lond)       Date:  2021-08-09       Impact factor: 4.456

Review 6.  Artificial intelligence for improving sickle cell retinopathy diagnosis and management.

Authors:  Sophie Cai; Ian C Han; Adrienne W Scott
Journal:  Eye (Lond)       Date:  2021-05-06       Impact factor: 4.456

7.  Imaging Features of Vessels and Leakage Patterns Predict Extended Interval Aflibercept Dosing Using Ultra-Widefield Angiography in Retinal Vascular Disease: Findings From the PERMEATE Study.

Authors:  Azam Moosavi; Natalia Figueiredo; Prateek Prasanna; Sunil K Srivastava; Sumit Sharma; Anant Madabhushi; Justis P Ehlers
Journal:  IEEE Trans Biomed Eng       Date:  2021-05-21       Impact factor: 4.756

8.  Exploring the angiographic-biologic phenotype in the IMAGINE study: quantitative UWFA and cytokine expression.

Authors:  Joseph R Abraham; Charles C Wykoff; Sruthi Arepalli; Leina Lunasco; Hannah J Yu; Alison Martin; Christopher Mugnaini; Ming Hu; Jamie Reese; Sunil K Srivastava; David M Brown; Justis P Ehlers
Journal:  Br J Ophthalmol       Date:  2021-06-07       Impact factor: 5.908

9.  Radiomics-based assessment of ultra-widefield leakage patterns and vessel network architecture in the PERMEATE study: insights into treatment durability.

Authors:  Prateek Prasanna; Vishal Bobba; Natalia Figueiredo; Duriye Damla Sevgi; Cheng Lu; Nathaniel Braman; Mehdi Alilou; Sumit Sharma; Sunil K Srivastava; Anant Madabhushi; Justis P Ehlers
Journal:  Br J Ophthalmol       Date:  2020-08-19       Impact factor: 5.908

10.  Insights into retinal hemangioblastoma using ultra widefield imaging.

Authors:  Pradeep Kumar; Raghav Ravani; Sahil Agarwal; Suman Dhanda; Vinod Kumar
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.